115 related articles for article (PubMed ID: 16630292)
1. Parotid carcinoma: expression of kit protein and epidermal growth factor receptor.
Sørensen KB; Godballe C; de Stricker K; Krogdahl A
J Oral Pathol Med; 2006 May; 35(5):286-91. PubMed ID: 16630292
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
4. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-kit in adenoid cystic carcinoma of the breast.
Crisi GM; Marconi SA; Makari-Judson G; Goulart RA
Am J Clin Pathol; 2005 Nov; 124(5):733-9. PubMed ID: 16203286
[TBL] [Abstract][Full Text] [Related]
6. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
Holst VA; Marshall CE; Moskaluk CA; Frierson HF
Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
[TBL] [Abstract][Full Text] [Related]
7. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
8. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
Vranic S; Frkovic-Grazio S; Lamovec J; Serdarevic F; Gurjeva O; Palazzo J; Bilalovic N; Lee LM; Gatalica Z
Hum Pathol; 2010 Nov; 41(11):1617-23. PubMed ID: 20688355
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.
Sung JY; Ahn HK; Kwon JE; Jeong H; Baek CH; Son YI; Ahn YC; Park K; Ahn MJ; Ko YH
J Oral Pathol Med; 2012 May; 41(5):415-23. PubMed ID: 22077630
[TBL] [Abstract][Full Text] [Related]
10. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma.
Mino M; Pilch BZ; Faquin WC
Mod Pathol; 2003 Dec; 16(12):1224-31. PubMed ID: 14681323
[TBL] [Abstract][Full Text] [Related]
11. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.
Beltran D; Faquin WC; Gallagher G; August M
J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803
[TBL] [Abstract][Full Text] [Related]
12. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma.
Penner CR; Folpe AL; Budnick SD
Mod Pathol; 2002 Jul; 15(7):687-91. PubMed ID: 12118104
[TBL] [Abstract][Full Text] [Related]
13. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
14. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations.
Aubry MC; Heinrich MC; Molina J; Lewis JE; Yang P; Cassivi SD; Corless CL
Cancer; 2007 Dec; 110(11):2507-10. PubMed ID: 17932891
[TBL] [Abstract][Full Text] [Related]
15. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin.
Vered M; Braunstein E; Buchner A
Head Neck; 2002 Jul; 24(7):632-6. PubMed ID: 12112535
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
18. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]